Research theme for competitive and other funds (14):
2021 - 2024 皮膚2型自然リンパ球がアトピー性皮膚炎に与える影響の研究
2018 - 2021 IL-33によって誘導される皮膚炎の分子病態に関する研究
2017 - 2019 IL-33R(+) cells and atopic dermatitis
2016 - 2018 Therapiutic effects of mesenchymal stem cells (MSCs) for dermatitis
2015 - 2018 Mechanisms of dermatitis and group 2 innate lymphoid cells (ILC2) activation
2014 - 2017 The induction of alarmins in keratinization disorders
2014 - 2016 Dermatitis and activation of IL-33
2013 - 2016 Research on activation of interleukin 36 in skin
2012 - 2014 Analysis of the therapeutic role of the inflammatory skin disease by IL-27
2011 - 2013 Various phenotypes and pathophysiology of congenital ichthyoses
2011 - 2012 Regulation of allergic skin disorders by nuocytes
2010 - 2011 Analysis of IL-33 in inflammatory skin disease
2008 - 2010 Transglutaminase and protein polymerization in keratinization
2008 - 2010 The function of protease-activated receptor in keratinocytes
Show all
Papers (56):
Yuka Hosotani, Koubun Yasuda, Makoto Nagai, Kiyofumi Yamanishi, Nobuo Kanazawa, Fumi Gomi, Yasutomo Imai. IL-33-induced keratoconjunctivitis is mediated by group 2 innate lymphoid cells in mice. Allergology international : official journal of the Japanese Society of Allergology. 2023. 72. 2. 324-331
Shohei Iida, Takehisa Nakanishi, Fumiyasu Momose, Masako Ichishi, Kento Mizutani, Yoshiaki Matsushima, Ai Umaoka, Makoto Kondo, Koji Habe, Yoshifumi Hirokawa, et al. IL-17A Is the Critical Cytokine for Liver and Spleen Amyloidosis in Inflammatory Skin Disease. International Journal of Molecular Sciences. 2022. 23. 10. 5726-5726
Masako Matsutani, Yasutomo Imai, Yukako Inoue, Minori Nakatani-Kusakabe, Masaru Natsuaki, Kiyofumi Yamanishi, Nobuo Kanazawa. Effectiveness and safety of tacrolimus ointment combined with dupilumab for patients with atopic dermatitis in real-world clinical practice. Journal of Dermatology. 2021. 48. 10. 1564-1568
Takayuki Sassa, Yasutomo Imai, Akio Kihara, Kiyofumi Yamanishi. Protein-bound ceramide levels in the epidermis of transglutaminase 1-deficient mice. The Journal of dermatology. 2021
Mayu Fujimoto, Makoto Nagai, Yasutomo Imai, Masaru Natsuaki, Nobuo Kanazawa. A case of angiosarcoma with a chief complaint of facial edema. Skin Research. 2021. 20. 3. 197-202
Kiyofumi Yamanishi, Yasutomo Imai. Alarmins/stressorins and immune dysregulation in intractable skin disorders. Allergology International. 2021. 70. 4. 421-429
Hideki Hayashi, Minori Kusakabe, Makoto Nagai, Yasutomo Imai, Kiyofumi Yamanishi. Switching to ixekizumab improves adalimumab-induced interstitial lung disease in patients with psoriatic arthritis: A case report. Journal of Cutaneous Immunology and Allergy. 2021. 4. 1. 22-23
Masako Matsutani, Yasutomo Imai, Minori Nakatani-Kusakabe, Masaru Natsuaki, Kiyofumi Yamanishi, Nobuo Kanazawa. Dupilumab in atopic dermatitis patients with chronic hepatitis B. Journal of Cutaneous Immunology and Allergy. 2021
Marin Kunimoto, Yasutomo Imai, Masako Matsutani, Minori Nakatani-Kusakabe, Makoto Nagai, Masaru Natsuaki, Kiyofumi Yamanishi, Nobuo Kanazawa. Evaluation of long-term disease control with dupilumab therapy using the Atopic Dermatitis Control Tool in real-world clinical practice. Journal of Cutaneous Immunology and Allergy. 2021
Masako Matsutani, Yasutomo Imai, Yukako Inoue, Yuka Hosotani, Minori Kusakabe, Masaru Natsuaki, Kiyofumi Yamanishi. Real-world use of dupilumab for 53 patients with atopic dermatitis in Japan. Journal of Cutaneous Immunology and Allergy. 2020. 3. 2. 35-36